INIFY Stock Overview
Provides cancer diagnostics services in Sweden. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
INIFY Laboratories AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 4.68 |
| 52 Week High | NOK 14.45 |
| 52 Week Low | NOK 4.06 |
| Beta | 0 |
| 11 Month Change | -28.00% |
| 3 Month Change | -44.94% |
| 1 Year Change | -57.45% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -53.20% |
Recent News & Updates
Recent updates
Shareholder Returns
| INIFY | NO Healthcare | NO Market | |
|---|---|---|---|
| 7D | 3.5% | -1.0% | 3.1% |
| 1Y | -57.5% | 5.3% | 3.9% |
Return vs Industry: INIFY underperformed the Norwegian Healthcare industry which returned 5.3% over the past year.
Return vs Market: INIFY underperformed the Norwegian Market which returned 3.9% over the past year.
Price Volatility
| INIFY volatility | |
|---|---|
| INIFY Average Weekly Movement | 16.0% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in NO Market | 10.6% |
| 10% least volatile stocks in NO Market | 2.7% |
Stable Share Price: INIFY's share price has been volatile over the past 3 months compared to the Norwegian market.
Volatility Over Time: INIFY's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Norwegian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | n/a | Fredrik Palm | www.inify.com |
INIFY Laboratories AB provides cancer diagnostics services in Sweden. It offers prostate cancer diagnostics services. The company was incorporated in 2021 and is based in Stockholm, Sweden.
INIFY Laboratories AB Fundamentals Summary
| INIFY fundamental statistics | |
|---|---|
| Market cap | NOK 212.61m |
| Earnings (TTM) | NOK 0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs INIFY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| INIFY income statement (TTM) | |
|---|---|
| Revenue | NOK 0 |
| Cost of Revenue | NOK 0 |
| Gross Profit | NOK 0 |
| Other Expenses | NOK 0 |
| Earnings | NOK 0 |
Last Reported Earnings
n/a
Next Earnings Date
Feb 26, 2025
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did INIFY perform over the long term?
See historical performance and comparison